Zobrazeno 1 - 10
of 420
pro vyhledávání: '"J. Drevs"'
Autor:
Liu, Yuchen1 (AUTHOR), Khoury, Luai R.1 (AUTHOR) luaikh@technion.ac.il
Publikováno v:
Small Science. Oct2024, Vol. 4 Issue 10, p1-12. 12p.
Autor:
J. Drevs
Publikováno v:
Der Klinikarzt. 35:94-98
Publikováno v:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 46:1050-1054
Autor:
C Brindley, J Drevs, A Perschl, A. van Oosterom, R. Hoekstra, Ferry A.L.M. Eskens, Herlinde Dumez, Jaap Verweij, W. Wynendaele, S Böttcher
Publikováno v:
European Journal of Cancer. 39:917-926
A single-agent dose escalating phase I and pharmacokinetic study with Cilengitide, an inhibitor of the integrins alphavbeta3 and alphavbeta5, was performed to determine its safety and toxicity. Cilengitide was administered as a one-hour infusion twic
Publikováno v:
Der Chirurg. 81:930-932
Das Auftreten einer bronchopleuralen Fistel ist eine ernste Komplikation nach Pneumonektomie aufgrund eines Lungenkarzinoms und die zusatzliche Bronchusstumpfdeckung gilt daher bei rechts- und linksseitiger Pneumonektomie als operativer Standard. In
Publikováno v:
Journal of clinical pharmacy and therapeutics. 38(1)
Auron Misheil therapy (AMT) is a combination of widely used pharmaceuticals and herbal components that has been used since the 1980s as a supportive therapy, mainly in end-stage cancer patients on a compassionate basis. This phase I study was conduct
Publikováno v:
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 81(10)
The occurrence of bronchopleural fistulas is a serious complication after pneumonectomy because of lung cancer and additional bronchial stump coverage within right-sided and left-sided pneumonectomy therefore constitutes the operative standard. This
Autor:
Clemens Unger, J. Drevs
Publikováno v:
Tumor Angiogenesis ISBN: 9783540331766
New blood vessel formation is fundamental to tumour growth and spread. The key signalling molecules involved in the promotion of tumour angiogenesis are the vascular endothelial growth factors (VEGF), which exert their effects by binding to tyrosine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f6181ec1ffb7ed5c9d1a2f619ec5961
https://doi.org/10.1007/978-3-540-33177-3_37
https://doi.org/10.1007/978-3-540-33177-3_37
Autor:
Jürgen Schwab, Cornelia Stockmar, Clemens Unger, Caterina Bissantz, Caterina Hinderling, J. Drevs, Norbert Esser, Peter Lazar, Peter Drückes, Iduna Fichtner, Gerd Folkers, Didier Rognan, Felix Kratz, André Warnecke, Karin Scheuermann
Publikováno v:
Journal of medicinal chemistry. 45(25)
We have recently proposed a macromolecular prodrug strategy for improved cancer chemotherapy based on two features (Kratz, F.; et al. J. Med. Chem 2000, 43, 1253-1256.): (a) rapid and selective binding of thiol-reactive prodrugs to the cysteine-34 po
Autor:
J, Drevs, I, Hofmann, H, Hugenschmidt, C, Wittig, H, Madjar, M, Müller, J, Wood, G, Martiny-Baron, C, Unger, D, Marmé
Publikováno v:
Cancer research. 60(17)
Antiangiogenic therapy is a promising new strategy to inhibit tumor growth and formation of metastases. Vascular endothelial growth factor (VEGF) and its receptors, VEGF-receptor 1 (VEGF-R1; FLT-1) and VEGF-R2 (KDR), have been shown to play a major r